284 related articles for article (PubMed ID: 10643074)
21. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.
Banfi S; Caruso E; Caprioli S; Mazzagatti L; Canti G; Ravizza R; Gariboldi M; Monti E
Bioorg Med Chem; 2004 Sep; 12(18):4853-60. PubMed ID: 15336264
[TBL] [Abstract][Full Text] [Related]
23. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
24. Induction of Hsp60 by Photofrin-mediated photodynamic therapy.
Hanlon JG; Adams K; Rainbow AJ; Gupta RS; Singh G
J Photochem Photobiol B; 2001 Nov; 64(1):55-61. PubMed ID: 11705730
[TBL] [Abstract][Full Text] [Related]
25. Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma.
Nonaka T; Nanashima A; Nonaka M; Uehara M; Isomoto H; Nonaka Y; Nagayasu T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):592-600. PubMed ID: 21360081
[TBL] [Abstract][Full Text] [Related]
26. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L; Sotti G
Lasers Surg Med; 2007 Jun; 39(5):394-402. PubMed ID: 17565719
[TBL] [Abstract][Full Text] [Related]
27. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).
Fingar VH; Kik PK; Haydon PS; Cerrito PB; Tseng M; Abang E; Wieman TJ
Br J Cancer; 1999 Apr; 79(11-12):1702-8. PubMed ID: 10206280
[TBL] [Abstract][Full Text] [Related]
28. Effects of photodynamic therapy combined with methotrexate on C6 rat glioma cells: a preliminary study.
LoRusso AP; Yu W; Naim JO; Lanzafame RJ
J Clin Laser Med Surg; 1996 Apr; 14(2):55-8. PubMed ID: 9484076
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of photofrin, 5-aminolevulinic acid and calphostin C on glioma cells.
Au CM; Luk SK; Jackson CJ; Ng HK; Yow CM; To SS
J Photochem Photobiol B; 2006 Nov; 85(2):92-101. PubMed ID: 16829117
[TBL] [Abstract][Full Text] [Related]
30. The experimental research of R-phycoerythrin subunits on cancer treatment: a new photosensitizer in PDT.
Huang B; Wang GC; Zeng CK; Li ZG
Cancer Biother Radiopharm; 2002 Feb; 17(1):35-42. PubMed ID: 11915172
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.
Morrison SA; Hill SL; Rogers GS; Graham RA
J Surg Res; 2014 Dec; 192(2):235-41. PubMed ID: 25043529
[TBL] [Abstract][Full Text] [Related]
32. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy with photofrin reduces invasiveness of malignant human glioma cells.
Jiang F; Chopp M; Katakowski M; Cho KK; Yang X; Hochbaum N; Tong L; Mikkelsen T
Lasers Med Sci; 2002; 17(4):280-8. PubMed ID: 12417983
[TBL] [Abstract][Full Text] [Related]
34. Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.
Wang LW; Huang Z; Lin H; Li ZS; Hetzel F; Liu Md B
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):244-251. PubMed ID: 23993850
[TBL] [Abstract][Full Text] [Related]
35. The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.
Yang PW; Chiang TH; Hsieh CY; Huang YC; Wong LF; Hung MC; Tsai JC; Lee JM
Lasers Med Sci; 2015 Dec; 30(9):2353-61. PubMed ID: 26450615
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model.
Middelkamp-Hup MA; Sánchez-Carpintero I; Kossodo S; Waterman P; González S; Mihm MC; Anderson RR
J Invest Dermatol; 2003 Sep; 121(3):634-9. PubMed ID: 12925226
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells.
Chang CJ; Sun CH; Liaw LH; Berns MW; Nelson JS
Lasers Surg Med; 1999; 24(3):178-86. PubMed ID: 10229148
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells.
King DE; Jiang H; Simkin GO; Obochi MO; Levy JG; Hunt DW
Scand J Immunol; 1999 Feb; 49(2):184-92. PubMed ID: 10075023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]